慢性肾脏病患者的血红蛋白轨迹与主要不良心血管事件风险
基于法国CKD-REIN队列3011例中重度CKD患者5年数据,采用联合潜在类别模型识别出5种血红蛋白轨迹。约三分之二患者轨迹稳定且事件风险低,其余三分之一呈非线性下降轨迹,MACE风险不同,且肾脏替代治疗启动与非心血管死亡风险随血红蛋白下降持续升高。
要点
- 约62.6%(1885例)CKD患者血红蛋白轨迹稳定且事件风险低。
- 其余三分之一呈非线性下降轨迹,不同轨迹MACE风险不同。
- 肾脏替代治疗与非心血管死亡风险随血红蛋白下降持续升高。
核心结论
- 本研究中约三分之二患者血红蛋白轨迹稳定且不良事件风险低,其余三分之一呈不同速率非线性下降轨迹且事件风险增加。
研究设计与样本
- 基于法国40家全国代表性肾脏病诊所入组的中重度CKD患者CKD-REIN队列5年纵向数据,共3011例受试者,采用联合潜在类别模型估计血红蛋白轨迹类别及竞争风险。
主要发现
- 识别出5种血红蛋白轨迹:稳定型1885例(62.6%)、早期强下降型257例(8.5%)、晚期强下降型75例(2.5%)、早期中度下降型356例(11.8%)、晚期中度下降型438例(14.6%)。
- 4种下降轨迹的MACE风险不同,而肾脏替代治疗启动与非心血管死亡风险随血红蛋白下降持续升高。
关键数值与推荐
- MACE+定义为心血管死亡、非致死性心肌梗死、卒中或急性心力衰竭住院中的首个事件。
临床怎么用
- 应更关注CKD患者血红蛋白的动态变化。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The trajectories of haemoglobin in patients with chronic kidney disease (CKD) have been poorly described. In such patients, we aimed to identify typical haemoglobin trajectory profiles and estimate their risks of major adverse cardiovascular events (MACE). METHODS: We used 5-year longitudinal data from the CKD-REIN cohort patients with moderate to severe CKD enrolled from 40 nationally representative nephrology clinics in France. A joint latent class model was used to estimate, in different classes of haemoglobin trajectory, the competing risks of (i) MACE + defined as the first event among cardiovascular death, non-fatal myocardial infarction, stroke or hospitalization for acute heart failure, (ii) initiation of kidney replacement therapy (KRT) and (iii) non-cardiovascular death. RESULTS: During the follow-up, we gathered 33 874 haemoglobin measurements from 3011 subjects (median, 10 per patient). We identified five distinct haemoglobin trajectory profiles. The predominant profile (n = 1885, 62.6%) showed an overall stable trajectory and low risks of events. The four other profiles had nonlinear declining trajectories: early strong decline (n = 257, 8.5%), late strong decline (n = 75, 2.5%), early moderate decline (n = 356, 11.8%) and late moderate decline (n = 438, 14.6%). The four profiles had different risks of MACE, while the risks of KRT and non-cardiovascular death consistently increased from the haemoglobin decline. CONCLUSION: In this study, we observed that two-thirds of patients had a stable haemoglobin trajectory and low risks of adverse events. The other third had a nonlinear trajectory declining at different rates, with increased risks of events. Better attention should be paid to dynamic changes of haemoglobin in CKD.
引用
- Le Gall L, Harambat J, Combe C, et al. Haemoglobin trajectories in chronic kidney disease and risk of major adverse cardiovascular events. Nephrol Dial Transplant. 2024. PMID: 37935529. doi:10.1093/ndt/gfad235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。